EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Placebo Effects and Neuromodulation: Ethical Considerations and Recommendations

Adriano Mollica iD, Rachel Greben, Marieve Cyr, Jay A Olson, Matthew J Burke

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2023

DOI: 10.1017/cjn.2023.24 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2023. Verfasst von Adriano Mollica und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neuropsychiatry Program, Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Placebo Effect, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 18-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Placebo-controlled trials are the gold standard of evaluating treatment efficacy in clinical research. Neuromodulation is emerging as an important treatment pathway for many neuropsychiatric conditions, and placebo control arms of these trials require careful design with unique considerations (e.g., sham devices that mimic active stimulation, blinding effectiveness). Inherent to placebo-controlled trials are ethical concerns, such as deception, and potential harm of not receiving the active treatment. In this article, we outline important ethical considerations of placebo-controlled trials across neuromodulation approaches and provide recommendations on how ethical principles can be adhered to going forward. We specifically address issues of autonomy and respect for persons, beneficence, and justice. Within the context of this ethical framework, we also discuss factors influencing placebo effects in neuromodulation, the importance of adequate blinding, and alternative trial designs that could be considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Placebo EffectRandomized Controlled Trials as TopicHumansRespectPersonal AutonomySocial Justice

Stichwörter der Autor:innen

Clinical trial methodologyNeuromodulationNeurotechnologyPlacebo

Autor:innen und Institutionen

  • Neuropsychiatry Program, Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Harquail Centre for Neuromodulation and Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada.
  • Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Faculty of Medicine, McGill University, Montreal, QC, Canada.
  • Department of Psychology, McGill University, Montreal, QC, Canada.
  • Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

ORCID-Profile: Adriano Mollica

Zitieren

APA

Mollica, A., Greben, R., Cyr, M., Olson, J. A., & Burke, M. J. (2023). Placebo Effects and Neuromodulation: Ethical Considerations and Recommendations. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/cjn.2023.24

Vancouver

Mollica A, Greben R, Cyr M, Olson JA, Burke MJ. Placebo Effects and Neuromodulation: Ethical Considerations and Recommendations. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2023. doi:10.1017/cjn.2023.24

BibTeX
@article{Mollica2023,
  author = {Mollica, Adriano and Greben, Rachel and Cyr, Marieve and Olson, Jay A and Burke, Matthew J},
  title = {Placebo Effects and Neuromodulation: Ethical Considerations and Recommendations},
  journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
  year = {2023},
  doi = {10.1017/cjn.2023.24}
}
Kostenlos starten →